Asset Details
Do you wish to reserve the book?
Missense variants in PRKCD: elucidating their potential association with breast cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Missense variants in PRKCD: elucidating their potential association with breast cancer
Do you wish to request the book?
Missense variants in PRKCD: elucidating their potential association with breast cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Missense variants in PRKCD: elucidating their potential association with breast cancer
2025
Overview
Background
Missense single-nucleotide polymorphisms (SNPs) in various genetic pathways can lead to the development of breast cancer. Protein kinase C delta (
PRKCD)
is involved in various important cellular pathways, and its altered expression has been identified in different cancers. Genetic alteration in this gene can be involved in cancer onset and progression. To date, there are no studies performed to elucidate the role of
PRKCD
missense variants in the development of breast cancer. Therefore, this study aims to identify the association of pathogenic missense SNPs in
PRKCD
with breast cancer.
Methods
The missense variants of
PRKCD
were retrieved from the Ensembl and dbSNP databases. Missense variants were analysed through various computational tools, and four variants of
PRKCD
rs1703806197
(T/C)
, rs782555227
(G/A)
, rs1703449438
(T/C)
, and rs1575535582 (
T/G
) were selected from the data. The genotype analysis for these variants was performed for 360 breast cancer patients and 363 healthy controls. Statistical association of variants with breast cancer clinical features was determined through chi-square/Fisher’s exact test with a significant
P
value
≤
0.05 using GraphPad Prism 8.0 software.
Results
Genotype analysis of
PRKCD
variants showed that missense SNPs rs782555227 (
G/A
), rs1703449438 (
T/C
), and rs1575535582 (
T/G
) were associated with breast cancer (
P
value < 0.05). Furthermore, genotypes in these SNPs were also found to be associated with various clinical features of breast cancer patients. Genotypes AG, TC, and TT in variants rs782555227, rs1703449438, and rs1575535582, respectively, were associated with breast cancer metastasis. While genotype AG of variant rs782555227 was also found to be associated with menopausal status and hereditary breast cancer. Moreover, genotype TT in variant rs1575535582 was associated with
BRCA1
positive status among the breast cancer patients.
Conclusion
The present study identified for the first time the association of specific
PRKCD
missense variants with breast cancer. These variants could be developed into possible genetic markers for the diagnosis of breast cancer at an early stage; however, further validation studies with a multiethnic large cohort size are required. Furthermore, functional studies of these variants will also aid in attaining insight into the molecular mechanisms through which these missense variants are involved in breast cancer.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Aged
/ Analysis
/ Biomedical and Life Sciences
/ Breast Neoplasms - pathology
/ Cancer
/ Ethylenediaminetetraacetic acid
/ Female
/ Females
/ Genes
/ Genetic Predisposition to Disease
/ Genotype
/ Humans
/ Kinases
/ Oncology
/ Polymorphism, Single Nucleotide
/ Protein Kinase C-delta - genetics
/ Single nucleotide polymorphisms
